ABOUT THE PRODUCT
HuidaGene is developing CRISPR-cas13 therapeutics for a range of diseases, utilizing our proprietary technology platform to deliver precise gene editing solutions.
Information is owner-confirmed
Last updated 1 month ago
Price range
N/A
